PRI's Focus on Health Care

View this email in your browser ([link removed])
Coronavirus response – Buy America push would hurt US. Here’s how
Fox News | Sally C. Pipes
May 17, 2020

This push is misguided. The administration’s “Buy America” agenda would derail our response to COVID-19 and could have long-lasting negative consequences for our economy. The best way to maintain efficient, high-quality production of drugs and other medical equipment is to embrace a dynamic, global supply chain.
Read more. . . ([link removed])

Anti-Science Precautionary Principle Jeopardizes Health, Safety, And Risks Innovation
Forbes.com | Wayne Winegarden
May 18, 2020

A new potential regulation in the EU – so-called “authorization” – could lead to banning silicones in certain uses and, if adopted widely, could ultimately risk the efficacy of medical devices and supplies. This would include products produced and imported into the EU.
Read more. . . ([link removed])
[link removed]
Last Chance to Register for PRI "Medicare for All and the COVID-19 Crisis with Sally C. Pipes" Webinar on May 20 at 11 AM PST. ([link removed])

COBRA subsidies would constrict the economy
The Washington Examiner | Sally C. Pipes
May 18, 2020

In addition to bailing out insurers, the HEROES Act would disrupt the country’s economic recovery. Supplementing unemployment benefits with taxpayer-funded health coverage would discourage unemployed workers from looking for new jobs — or even returning to their old ones, once nonessential businesses reopen.

Read more. . . ([link removed])

Kooks, Crazies, And Coronavirus Conspiracies
Issues & Insights | Henry Miller, M.S., M.D. and Kathleen Hefferon, Ph.D.
May 18, 2020

The organic lobby isn’t merely attacking mainstream agriculture and medicine. Several “organic/alternative health” newsletters have claimed that organic foods can act as a kind of natural medicine that protects against COVID-19, and that pesticide residues found in non-organic crops “can weaken the immune system and increase vulnerability to Covid-19.”
Read more. . . ([link removed])
[link removed]
PRI Drug Pricing Video #4 - "Relay Race" to Develop New Medicines ([link removed])
The PRI Center for Medical Economics and Innovation released the fourth video ([link removed]) in its series about explaining drug innovation costs. Watch Professor Salvare take Pete Paystoomuch observe the government, the private sector, universities, and foundations pass the baton in a research relay race that is ultimately anchored by private companies who finish the race to develop new medicines that treat illnesses and create cures for devastating diseases.

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.